# Allergan Aesthetics to acquire Soliton for body contouring technology

Allergan Aesthetics, an AbbVie company, announced a definitive agreement to acquire Soliton and its RESONIC Rapid Acoustic Pulse device, a non-invasive treatment for cellulite. The acquisition expands Allergan Aesthetics' body contouring portfolio.

- Type: Acquisition
- Announced: 2021-05-10
- Where: United States
- Status: announced
- Products: Rapid Acoustic Pulse device for cellulite treatment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Allergan Aesthetics](https://endata.com/companies/55003.md) (acquirer)
- [Soliton](https://endata.com/companies/55004.md) (target)

## Sources

- [nasdaq.com](https://www.nasdaq.com/press-release/allergan-aesthetics-to-acquire-soliton-expanding-body-contouring-portfolio-2021-05-10), 2021-05-10: "The acquisition of Soliton expands and complements Allergan Aesthetics' Body Contouring treatment portfolio which includes CoolSculpting® Elite."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.